You are currently viewing the abstract.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Abstract
This Podcast features an interview with Eric Haura, author of a Research Resource that appears in the 18 October 2016 issue of Science Signaling, about using network biology to identify potential targets for combination therapies for treating lung cancers that have increased activity of the tyrosine kinase ALK.
